Literature DB >> 10471975

The importance of specific IgG and IgE autoantibodies to retinal S antigen, total serum IgE, and sCD23 levels in autoimmune and infectious uveitis.

J C Muiño1, C P Juárez, J D Luna, C C Castro, E G Wolff, M Ferrero, M D Romero-Piffiguer.   

Abstract

Autoimmunity plays an important role in the development of uveitis. The uveitis are linked to Th1 or Th2 lymphocyte activation. We studied 41 patients with uveitis, divided into autoimmune uveitis (n = 32) and infectious uveitis (n = 9), 30 normal controls, and 20 asthmatic atopic without ocular diseases. The infectious uveitis patients were separated into bacterial (n = 6) and toxoplasmic (n = 3) retinochoroiditis. We measured IgE and sCD23 serum levels and specific IgG and IgE to retinal S antigen by ELISA tests. The IgE levels were 500 +/- 325 kU/L in autoimmune uveitis, 57 +/- 35 kU/L in bacterial uveitis, 280 +/- 38 kU/L in toxoplasmic retinochoroiditis, 75 +/- 32 kU/L in the controls, and 557 +/- 243 kU/L in atopics (P < 0.0005). The sCD23 levels were 10.4 +/- 5.4 ng/ml in autoimmune uveitis, 3.7 +/- 1.17 ng/ml in bacterial uveitis, 6.76 +/- 1.36 ng/ml in toxoplasmic retinochoroiditis, 3.4 +/- 1 ng/ml in controls, and 8.35 +/- 2.2 ng/ml in atopic patients (P < 0.005). The specific IgG to retinal S antigen was positive in 27 of 32 cases, and the specific IgE to retinal S antigen was positive in 22 of 32 autoimmune uveitis. The bacterial uveitis patients as well as the controls were negative for both autoantibodies to retinal S antigen. The toxoplasmic retinochoroiditis patients presented specific IgG and IgE to retinal S antigen in two of three cases, respectively, one of them with overlap of both antibodies. These results suggest the importance of specific IgG and IgE to retinal S antigen in autoimmune uveitis, which, along with higher IgE and sCD23 levels, reveal Th2 activation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10471975     DOI: 10.1023/a:1020516029883

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  18 in total

1.  S-antigen: preparation and characterization of site-specific monoclonal antibodies.

Authors:  L A Donoso; D S Gregerson; L Smith; S Robertson; V Knospe; T Vrabec; C M Kalsow
Journal:  Curr Eye Res       Date:  1990-04       Impact factor: 2.424

2.  A new role for CD23 in inflammation.

Authors:  J Y Bonnefoy; C Plater-Zyberk; S Lecoanet-Henchoz; J F Gauchat; J P Aubry; P Graber
Journal:  Immunol Today       Date:  1996-09

Review 3.  Revisiting the Th1/Th2 paradigm.

Authors:  E Muraille; O Leo
Journal:  Scand J Immunol       Date:  1998-01       Impact factor: 3.487

Review 4.  Nitric oxide production by human monocytes: evidence for a role of CD23.

Authors:  B Dugas; M D Mossalayi; C Damais; J P Kolb
Journal:  Immunol Today       Date:  1995-12

5.  Serum soluble CD23 in patients with hypogammaglobulinaemia.

Authors:  A S Bansal; M R Haeney; S Cochrane; R S Pumphrey; L M Green; M Bhavnani; P B Wilson
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

6.  A simple and rapid method for isolation of retinal S antigen.

Authors:  C Dorey; J Cozette; J P Faure
Journal:  Ophthalmic Res       Date:  1982       Impact factor: 2.892

7.  Resident and infiltrating cells in the rat iris during the early stages of experimental melanin protein-induced uveitis (EMIU).

Authors:  P G McMenamin; J Crewe; A Kijlstra
Journal:  Ocul Immunol Inflamm       Date:  1997-12       Impact factor: 3.070

8.  IgE: an immunoglobulin specialized in antigen capture?

Authors:  G C Mudde; T T Hansel; F C von Reijsen; B F Osterhoff; C A Bruijnzeel-Koomen
Journal:  Immunol Today       Date:  1990-12

9.  Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus.

Authors:  A Bansal; T Roberts; E M Hay; R Kay; R S Pumphrey; P B Wilson
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

Review 10.  Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.

Authors:  H L Weiner; A Friedman; A Miller; S J Khoury; A al-Sabbagh; L Santos; M Sayegh; R B Nussenblatt; D E Trentham; D A Hafler
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

View more
  9 in total

Review 1.  Allergic ocular disease. A review of pathophysiology and clinical presentations.

Authors:  L Bielory; P E Goodman; E M Fisher
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  Aqueous humor and serum immunoblotting for immunoglobulin types G, A, M, and E in cases of human ocular toxoplasmosis.

Authors:  Justus G Garweg; Silvia-Daniela L Garweg; Franziska Flueckiger; Patrick Jacquier; Matthias Boehnke
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

3.  Anti-galectin-1 autoantibodies in human Trypanosoma cruzi infection: differential expression of this beta-galactoside-binding protein in cardiac Chagas' disease.

Authors:  L Giordanengo; S Gea; G Barbieri; G A Rabinovich
Journal:  Clin Exp Immunol       Date:  2001-05       Impact factor: 4.330

4.  The role of serology in active ocular toxoplasmosis.

Authors:  Marina Papadia; Raffaella Aldigeri; Carl P Herbort
Journal:  Int Ophthalmol       Date:  2012-01-11       Impact factor: 2.031

Review 5.  AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer-a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI).

Authors:  D Ferastraoaru; H J Bax; C Bergmann; M Capron; M Castells; D Dombrowicz; E Fiebiger; H J Gould; K Hartmann; U Jappe; G Jordakieva; D H Josephs; F Levi-Schaffer; V Mahler; A Poli; D Rosenstreich; F Roth-Walter; M Shamji; E H Steveling-Klein; M C Turner; E Untersmayr; S N Karagiannis; E Jensen-Jarolim
Journal:  Clin Transl Allergy       Date:  2020-07-17       Impact factor: 5.871

6.  Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis.

Authors:  Justus G Garweg; Yvonne de Kozak; Brigitte Goldenberg; Matthias Boehnke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-03       Impact factor: 3.117

7.  Autoantibodies Against Ubiquitous and Confined Antigens in Patients With Ocular, Neuro-Ophthalmic and Congenital Cerebral Toxoplasmosis.

Authors:  Monica Goldberg-Murow; Carlos Cedillo-Peláez; Luz Elena Concha-Del-Río; Rashel Cheja-Kalb; María José Salgar-Henao; Eduardo Orozco-Velasco; Héctor Luna-Pastén; Fernando Gómez-Chávez; Antonio Ibarra; Dolores Correa
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

Review 8.  Immunoglobulin E-Mediated Autoimmunity.

Authors:  Marcus Maurer; Sabine Altrichter; Oliver Schmetzer; Jörg Scheffel; Martin K Church; Martin Metz
Journal:  Front Immunol       Date:  2018-04-09       Impact factor: 7.561

9.  Correlation between serum immunoglobulin levels and retinal structure in patients with newly diagnosed Vogt‑Koyanagi‑Harada disease.

Authors:  Zhijian Jiang; Nan Zhang; Huiying Ji; Maoli Zhu; Min Zhou; Jianhong Dong
Journal:  Mol Med Rep       Date:  2022-07-29       Impact factor: 3.423

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.